title: Evaluation studies of the 13C-mixed triglyceride breath test in healthy controls and adult cystic fibrosis patients with exocrine pancreatic insufficiency.
abstract: The 13C-mixed triglyceride (13C-MTG) breath test (BT) is a safe and noninvasive method to measure exocrine pancreatic function. We examined the reproducibility of the 13C-MTG BT in a group of 17 healthy controls and 8 adult patients with cystic fibrosis (CF). In controls no statistically significant difference in percentage dose recovered (PDR) was found between the first and the second result of repeated tests: the mean values were 35.5 +/- 5.5 vs. 32.3 +/- 7.4 PDR (n = 17). Also in the group of CF patients (n = 8) no significant difference between duplicate tests was found: mean values 17.5 +/- 7.5 and 17.5 +/- 7.8 PDR, respectively. The coefficient of repeatability is 8 PDR for the controls and CF patients together. Two factors might influence the outcome of the test. First, individually measured CO2 excretion instead of the usually assumed 9 mmol/h/kg CO2 production might alter the result of the 13CO2-MTG BT. Therefore CO2 production was measured by indirect calorimetry in 12 healthy controls and 13 CF patients. Measured CO2 excretion was not significantly different between healthy controls and CF patients. Secondly, exercise might influence BT results due to its separate effects on both CO2 production and excretion. The influence of physical exercise at a level of 25 or 50 W was studied on a bicycle ergometer in 4 healthy controls during the last 5 min of each 30-min sampling period. Exercise gave lower test results, on average 85% of the PDR value at rest. Incidently, it was observed in 1 patient that use of 13C-enriched food during the day preceding the test caused inappropriately low test results in the 13C-MTG BT. The 13C-MTG BT is a test with a fair but less than desirable reproducibility. Test conditions should be standardized to eliminate confounding influences. Exercise should be limited or strictly defined. Diet on the day preceding the test should not contain naturally 13C-enriched food. There is no need to measure individual CO2 production.
authors.affiliation: Department of Internal Medicine II, University Hospital Dijkzigt, Rotterdam, The Netherlands. swart@inw2.azr.nl
authors.forename: G R
authors.initials: GR
authors.lastname: Swart
authors.forename: E A
authors.initials: EA
authors.lastname: Baartman
authors.forename: J L
authors.initials: JL
authors.lastname: Wattimena
authors.forename: T
authors.initials: T
authors.lastname: Rietveld
authors.forename: S E
authors.initials: SE
authors.lastname: Overbeek
authors.forename: J W
authors.initials: JW
authors.lastname: van den Berg
mesh_terms: D000328:Adult; D001944:Breath Tests / Q000379:methods; D002153:Calorimetry, Indirect; D002245:Carbon Dioxide / Q000032:analysis; D002247:Carbon Isotopes; D016022:Case-Control Studies; D003550:Cystic Fibrosis / Q000503:physiopathology*; D005069:Evaluation Studies as Topic; D015444:Exercise; D005080:Exercise Test; D010188:Exocrine Pancreatic Insufficiency / Q000175:diagnosis*; D005260:Female; D006801:Humans; D008049:Lipase / Q000378:metabolism; D008297:Male; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D014280:Triglycerides
chemical_list: D002247:Carbon Isotopes; D014280:Triglycerides; D002245:Carbon Dioxide; D008049:Lipase